<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ischemic <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">disorders of brain</z:e> blood circulation caused by brain artery <z:mp ids='MP_0005048'>thrombosis</z:mp> due to antiphospholipids-induced anticoagulopathy are main neurological appearances of <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (PAPS) </plain></SENT>
<SENT sid="1" pm="."><plain>A number of <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e> in patients with PAPS are the result of primary involvement of the brain and peripheral <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
<SENT sid="2" pm="."><plain>We analyzed the spectrum of neurological non-ischemic PAPS manifestations in 125 patients (102 female, 23 male, mean age--37.5 +/- 11.3 years) with definite PAPS </plain></SENT>
<SENT sid="3" pm="."><plain>These manifestations included <z:hpo ids='HP_0002315'>headache</z:hpo> (67%), <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> (23%), <z:hpo ids='HP_0002072'>chorea</z:hpo> (15%), <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> (9%), <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> (6%), multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> like syndrome (MSLS) (8%), <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0000709'>psychosis</z:hpo> (2%), <z:e sem="disease" ids="C0022972,C0549225" disease_type="Disease or Syndrome" abbrv="">myasthenic syndrome</z:e> (1%), non-vascular <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> (1%) </plain></SENT>
<SENT sid="4" pm="."><plain>In the development of non-ischemic PAPS manifestations, antiphospholipids as well as other antibodies produced as a result of immune disregulation (antibodies to <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> receptors in <z:e sem="disease" ids="C0022972,C0549225" disease_type="Disease or Syndrome" abbrv="">myasthenic syndrome</z:e>, antineuronal antibodies in MSLS) may have pathogenic significance </plain></SENT>
<SENT sid="5" pm="."><plain>In some cases a role of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> involved in PAPS manifestation cannot be ruled out </plain></SENT>
</text></document>